Form 4: Protagonist Therapeutics' Chief Medical Officer, Arturo Molina, Executes Stock Options and Sells Shares

Arturo Molina, Chief Medical Officer of Protagonist Therapeutics, exercised stock options and sold shares of common stock on March 13, 2025.

Summary

• On March 13, 2025, Arturo Molina, the Chief Medical Officer of Protagonist Therapeutics, exercised stock options to acquire 28,437 shares at $23.42 and 2,077 shares at $38.98.
• Following these transactions, Molina sold 30,514 shares at a weighted average price of $55.74, with individual sales ranging from $55.245 to $56.06.
• After these transactions, Molina directly owns 83,892 shares of Protagonist Therapeutics common stock.
• Molina also holds options to purchase 69,063 shares at $23.42 and 47,785 shares at $38.98.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions by an insider. The sentiment is neither particularly positive nor negative without additional context.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like the Chief Medical Officer, trade their company's stock. These filings provide transparency into insider transactions and can be monitored for insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• Shareholders may interpret the insider's stock sale as a signal, although it could be for personal financial reasons and not necessarily indicative of the company's performance.

Key Dates